Status:
RECRUITING
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
Lead Sponsor:
Genomic Prediction Inc.
Collaborating Sponsors:
Boston IVF
Conditions:
Infertility, Female
Eligibility:
FEMALE
35-40 years
Phase:
NA
Brief Summary
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transf...
Detailed Description
In this randomized controlled trial, a total of 240 patients divided evenly across the two participating IVF center will be recruited. Patients will be randomized to a control and to a treatment group...
Eligibility Criteria
Inclusion
- Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
- Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF
- Utilization of ejaculated or testicular sperm
- Utilization of autologous or donor sperm
- All Controlled Ovarian Hyperstimulation (COH) protocols
Exclusion
- Utilization of donor oocytes
- Utilization of gestational carrier
- Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
- Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers
- Preimplantation genetic testing for monogenic/single gene disorders (PGT-M)
- Translocation carriers
Key Trial Info
Start Date :
November 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 15 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06141135
Start Date
November 15 2023
End Date
November 15 2026
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston IVF
Waltham, Massachusetts, United States, 02451